Application 076643

Type
ANDA
Sponsor
RANBAXY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CARBILEVCARBIDOPA; LEVODOPATABLET, FOR SUSPENSION;ORAL10MG;100MGNoNo
002CARBILEVCARBIDOPA; LEVODOPATABLET, FOR SUSPENSION;ORAL25MG;100MGNoNo
003CARBILEVCARBIDOPA; LEVODOPATABLET, FOR SUSPENSION;ORAL25MG;250MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A076643-001CARBILEVCARBIDOPA; LEVODOPA10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10
A076643-002CARBILEVCARBIDOPA; LEVODOPA25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10
A076643-003CARBILEVCARBIDOPA; LEVODOPA25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2024-10-29 15:01 UTC2024-10A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10d06236e962d9…
2024-10-29 15:01 UTC2024-10A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-10d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-1079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-1079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-1079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-10301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-101e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-101e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-101e350fbaab3a…
2024-05-31 18:47 UTC2024-05A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-108072bd15b7f6…
2024-05-31 18:47 UTC2024-05A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-108072bd15b7f6…
2024-05-31 18:47 UTC2024-05A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-108072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-105c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-105c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-105c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-105d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-105d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-105d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-104b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-104b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-104b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-1074a2ff9319b5…
2019-12-13 00:20 UTC2019-12A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-1074a2ff9319b5…
2019-12-13 00:20 UTC2019-12A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-1074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-10bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10782e0a99824c…
2021-12-28 21:50 UTC2021-12A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-10782e0a99824c…
2021-12-28 21:50 UTC2021-12A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-10782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-1087673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-1087673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-1087673890dc5c…
2021-03-12 10:30 UTC2021-03A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-105aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-105aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03A076643-003CARBILEV25MG;250MGTABLET, FOR SUSPENSION / ORAL2005-06-105aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A076643-001CARBILEV10MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-108869cabd3fbd…
2020-12-22 03:56 UTC2020-12A076643-002CARBILEV25MG;100MGTABLET, FOR SUSPENSION / ORAL2005-06-108869cabd3fbd…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8941ORIG2005-06-14